SMTL ID : 7yq9.2 (1 other biounit)

Crystal structure of BRD4 bromodomain 1 (BD1) in complex with N-[2-(1H-indol-3-yl)ethyl]-3-(trifluoromethyl)[1,2,4]triazolo[4,3-b]pyridazin-6-amine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

monomer

Ligands

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 2 residues within 4Å: Chain A: R.17, Q.18 Ligand excluded by PLIP

1 x JLX: N-[2-(1H-indol-3-yl)ethyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine(Non-covalent)

JLX.2: 10 residues within 4Å: Chain A: W.40, P.41, V.46, L.51, L.53, Y.98, N.99, D.104, I.105, M.108 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:W.40, A:P.41, A:L.53, A:Y.98, A:D.104, A:I.105, A:I.105 Hydrogen bonds: A:N.99

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kim, J.H. et al., Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure-activity relationship study. Sci Rep (2023)

Release Date

2023-01-18

Peptides

Bromodomain-containing protein 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Bromodomain-containing protein 4

Related Entries With Identical Sequence